Cancer antigen-125 and hospital readmission and mortality outcomes in acute heart failure: a systematic review and meta-analysis

26 May 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Rafael de la Espriella

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)

13 More presentations in this session

Presentation thumbnail

Release of mitochondrial DNA is associated with mortality in acute heart failure

Doctor K. Krychtiuk (Vienna, AT)

Abstract Slides

Presentation thumbnail

Decreased number of endothelial progenitor cells to apoptotic endothelial cell-derived microparticle ratio predicts atrial fibrillation in acutly decompensatede heart failure

Professor A. Berezin (Salzburg, AT)

Abstract Slides

Presentation thumbnail

Single high-sensitivity cardiac troponin T measurement predicts 1-year mortality and CV events in real-world patients admitted to the emergency room with acute decompensated heart failure

Doctor M. Goncalves (Carnaxide, PT)

Presentation thumbnail

Thrombopoeitin as a biomarker and a regulatory mediator in acute heart failure

Professor L. Malinova (Saratov, RU)

Abstract Slides

Presentation thumbnail

The prognostic role of different renal function phenotypes in patients Hospitalized for Acute Heart Failure

Doctor G. Ruocco (Maastricht, NL)

Access the full session

Session thumbnail

Poster Session 1 - Acute Heart Failure – Diagnostic Methods

The Event

Heart Failure 2018

26 May - 29 May 2018

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Presentation

Novel concepts in the diagnosis of AHF in the emergency department

Congress Presentation

Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources